SENTINEL AXILLARY LYMPH NODE BIOPSY: THE DEPLORABLE SITUATION IN BRAZIL
Guidoux, J. R. O. (Breast Program, Teaching Hospital of the Federal U), Martins, E. (Breast Program, Teaching Hospital of the Federal U), Gouveia, P. A. (Breast Program, Teaching Hospital of the Federal U), RAHAL, R. M. S. (Breast Program, Teaching Hospit
SENTINEL AXILLARY LYMPH NODE BIOPSY: THE DEPLORABLE SITUATION IN BRAZIL
Guidoux, J. R. O. (Breast Program, Teaching Hospital of the Federal U), Martins, E. (Breast Program, Teaching Hospital of the Federal U), Gouveia, P. A. (Breast Program, Teaching Hospital of the Federal U), RAHAL, R. M. S. (Breast Program, Teaching Hospit
Breast Program, Teaching Hospital of the Federal University of Goiás, Goiânia, Goiás, BrazilObjective: Verify the amount of pacients with breast cancer, users of the Brazilian National Health System (Sistema Único de Saúde [SUS]), submitted to sentinel lymph node biopsy (SLNB), between 2008 and 2015, analyzing differences among the different regions of the country. Methodology: descriptive time-series study of the SLNB, according to the population-based database on hospital information (DATASUS/SIH), witch records all the oncologic procedures executed by SUS, submitted to SLNB, between 2008 and 2015. Results: during the report period, around 210.000 oncologic surgeries were performed in the country. Of this total, the number of axillary dissection performed was 9.717. Therefore, the number of SLNB was 909, distributed as followed: 3.52% in North, 13.53% in Northeast, 58.53% in Southeast, 19.8% in South and 4.63% in Midwest. Conclusion: This technique was first codified by the SUS in 2013, after the verification of the lower morbidity compared with the axillary dissection. However, the number of SLNB realized, in our country, during the years analyzed was far behind the number of lymphadenectomy, with significant differences among the country regions.axillary dissection, breast cancer, sentinel lymph node biopsy